NCT06802796View on ClinicalTrials.gov

Plasma NGAL in APN Patients

CompletedOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

February 1, 2024

Primary Completion Date

June 1, 2024

Study Completion Date

June 1, 2024

Conditions
Pyelonephritis
Interventions
DIAGNOSTIC_TEST

Plasma NGAL test

Human neutrophil gelatinase-associated lipocalin ELISA Kit from BT LAB® Bioassay technology laboratory was used for the estimation of serum NGAL. Procedure was done according to the manufacturer's instructions.

Trial Locations (1)

44749

Elsayed Abdelhalim Elsayed, Zagazig

All Listed Sponsors
lead

Kafrelsheikh University

OTHER

NCT06802796 - Plasma NGAL in APN Patients | Biotech Hunter | Biotech Hunter